SAN FRANCISCO, Sept. 23, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national shareholder rights firm, notifies investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) of a pending securities class action lawsuit.

Investors who purchased or acquired Aardvark common stock pursuant and/or traceable to the offering documents issued in connection with the Company's initial public offering (IPO) on or about February 13, 2025, and/or purchased or acquired Aardvark securities between February 13, 2025 and May 14, 2026 (the Class Period), are encouraged to contact our firm now.

Watch our video on the Aardvark investigation: youtu.be/pY5E36QoCqo

Key Case Details & Important Deadlines

- Lead Plaintiff Motion Deadline: October 13, 2026

- Visit: www.hbsslaw.com/aard

What is the Lawsuit About?

The complaint alleges that Aardvark Therapeutics, a clinical-stage biopharmaceutical company focused on developing small-molecule therapies targeting bitter taste receptors (TAS2Rs) such as ARD-101 for the treatment of hyperphagia in Prader-Willi Syndrome (PWS), made materially false and misleading statements and/or failed to disclose critical information.

Specifically, the action points out that the offering documents and defendants failed to disclose:

- That ARD-101 was significantly less safe than defendants had led investors to believe;

- That unexpected, reversible cardiac observations (such as QRS prolongation) occurred during trials at above-target doses; and

- Consequently, Aardvark's clinical, regulatory, and commercial prospects—including the Phase 3 Hunger Elimination or Reduction Objective (HERO) trial and open-label extension (OLE)—were materially overstated.

The Truth Emerges: Voluntarily Pause and FDA Clinical Hold

- February 27, 2026: Aardvark announced it was voluntarily pausing its Phase 3 HERO trial due to "reversible cardiac observations at above target therapeutic doses found during routine safety monitoring in a healthy volunteer study." Following this news, Aardvark's stock price plummeted over 56%.

- May 14, 2026: Aardvark announced that the U.S. Food and Drug Administration (FDA) placed a full clinical hold on its investigational new drug application (IND) for ARD-101, halting all ongoing studies under the IND, including the Phase 3 HERO trial and OLE trial. Aardvark's stock price fell another 32.1%.

Hagens Berman's Investigation

"We're investigating the suit's allegations, including that Aardvark allegedly misled investors about ARD-101's development, its safety and efficacy," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation of the claims in the pending suit.

What Can Aardvark Investors Do?

If you are a class member who suffered losses on Aardvark securities, you have until October 13, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. The firm welcomes AARD investors to contact the firm to discuss their legal rights and potential recovery options.

If you'd like more information and answers to frequently asked questions about the firm's Aardvark investigation, read more »

Whistleblowers: Persons with non-public information regarding Aardvark Therapeutics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

AerCap Holdings N.V. Announces Pricing of $1.5 Billion Aggregate Principal Amount of Senior Notes

DUBLIN, Sept. 23, 2026 /PRNewswire/ -- AerCap Funding Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of AerCap Holdings N.V. ("AerCap" or the "Company"), priced an offering of senior notes, consisting of $750 million aggregate principal amount of the Issuer's 5.500% Senior Notes due 2030 (the "2030 Notes") and $750 million aggregate principal amount of the Issuer's 5.875% Senior Notes due 2033 (the "2033 Notes" and, together with the 2030 Notes, the "Notes"). The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by the Company and certain other subsidiaries of the Company.

The Issuer intends to use the net proceeds from the Notes for general corporate purposes, including to acquire, invest in, finance or refinance aircraft assets and to repay indebtedness.

Citigroup, Mizuho, BNP PARIBAS, Deutsche Bank Securities, Santander and Truist Securities are serving as joint book-running managers for the underwritten public offering.

The Company has filed a registration statement (including a prospectus) on Form F-3 with the U.S. Securities and Exchange Commission (the "SEC") for the underwritten offering to which this communication relates. The registration statement automatically became effective upon filing on June 29, 2026. Investors should read the accompanying prospectus dated June 29, 2026, the preliminary prospectus supplement relating to the offering dated September 23, 2026, and other documents the Company has filed with the SEC for more complete information about the Company and this offering.

These documents may be obtained for free by visiting EDGAR on the SEC's website at www.sec.gov. The prospectus supplement and accompanying prospectus relating to this offering may also be obtained from: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-800-831-9146 or by email at prospectus@citi.com; Mizuho Securities USA LLC, Attn: Debt Capital Markets, 1271 Avenue of the Americas, New York, New York 10020, or by telephone at 1-866-271-7403; BNP Paribas Securities Corp., 787 Seventh Avenue, New York, NY 10019, by telephone at 1-800-854-5674, or by email at [email protected]; Deutsche Bank Securities Inc., 1 Columbus Circle, New York, NY 10019, Attn: Prospectus Group, by telephone at 1-800-503-4611 or by email at [email protected]; Santander US Capital Markets LLC, 437 Madison Avenue, New York, NY 10022, by telephone at 1-855-403-3636; or Truist Securities, Inc., 740 Battery Avenue SE, 3rd Fl, Atlanta, Georgia 30339, Attention: Prospectus Dept, or by calling toll-free at 1-800-685-4786, or by email at [email protected].

This press release shall not constitute an offer to sell or purchase or the solicitation of an offer to sell or purchase the Notes or any other securities, nor shall there be any offer, solicitation, purchase or sale of these securities in any state or jurisdiction in which such offer, solicitation, purchase or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About AerCap

AerCap is the global leader in aviation leasing with one of the most attractive order books in the industry. AerCap serves approximately 300 customers around the world with comprehensive fleet solutions. AerCap is listed on the New York Stock Exchange (AER) and is headquartered in Dublin with offices in Miami, Shannon, Memphis, Singapore, London, Dubai, Shanghai, Amsterdam and other locations around the world.

Forward-Looking Statements

This press release contains certain statements, estimates and forecasts with respect to future performance and events. These statements, estimates and forecasts are "forward-looking statements". In some cases, forward-looking statements can be identified by the use of forward-looking terminology such as "may," "might," "should," "expect," "plan," "intend," "will," "aim," "estimate," "anticipate," "believe," "predict," "potential" or "continue" or the negatives thereof or variations thereon or similar terminology. All statements other than statements of historical fact included in this press release are forward-looking statements and are based on various underlying assumptions and expectations and are subject to known and unknown risks, uncertainties and assumptions, and may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied in the forward-looking statements, including but not limited to the availability of capital to us and to our customers and changes in interest rates; the ability of our lessees and potential lessees to make lease payments to us; our ability to successfully negotiate flight equipment (which includes aircraft, engines and helicopters) purchases, sales and leases, to collect outstanding amounts due and to repossess flight equipment under defaulted leases, and to control costs and expenses; changes in the overall demand for commercial aviation leasing and aviation asset management services; the continued impacts of the Ukraine Conflict, including the resulting sanctions by the United States, the European Union, the United Kingdom and other countries, on our business and results of operations, financial condition and cash flows; the effects of terrorist attacks on the aviation industry and on our operations; the economic condition of the global airline and cargo industry and economic and political conditions; the impact of hostilities in the Middle East, or any escalation thereof, on the aviation industry or our business; trade tensions, including U.S. tariffs and retaliatory measures by the European Union, China and other countries, and the resulting geopolitical uncertainty; development of increased government regulation, including travel restrictions, sanctions, regulation of trade and the imposition of import and export controls, tariffs and other trade barriers; a downgrade in any of our credit ratings; competitive pressures within the industry; regulatory changes affecting commercial flight equipment operators, flight equipment maintenance, engine standards, accounting standards and taxes; and disruptions and security breaches affecting our information systems or the information systems of our third-party providers.

As a result, we cannot assure you that the forward-looking statements included in this press release will prove to be accurate or correct. These and other important factors and risks are discussed in AerCap's annual report on Form 20-F and other filings with the SEC. In light of these risks, uncertainties and assumptions, the future performance or events described in the forward-looking statements in this press release might not occur. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. Except as required by applicable law, we do not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE AerCap Holdings N.V.

Share this article

AUSTIN, Texas, Sept. 23, 2026 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the third quarter of 2026 on Tuesday, November 3, 2026, after the market closes.

The Company will conduct its quarterly conference call on Wednesday, November 4, 2026, at 9:00 AM ET.

- To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details.

- A live webcast of the conference call can be accessed using this link. A replay of the webcast will be available in the Investors section of the Company's website, www.shpreit.com, until February 1, 2027.

About Summit Hotel Properties

Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging facilities with efficient operating models primarily in the upscale segment of the lodging industry. As of September 23, 2026, the Company's portfolio consisted of 92 assets, 50 of which are wholly owned, with a total of 14,027 guestrooms located in 24 states.

For additional information, please visit the Company's website, www.shpreit.com, and follow on X at @SummitHotel_INN.

SOURCE Summit Hotel Properties, Inc.

Share this article

CSQUARE CEO TO SPEAK AT 2026 RBC CAPITAL MARKETS GLOBAL COMMUNICATIONS INFRASTRUCTURE CONFERENCE

English

DALLAS, Sept. 23, 2026 /PRNewswire/ -- Csquare, Inc. (NYSE: CSQR), a leading provider of carrier-neutral colocation data centers, today announced its CEO Spencer Mullee will speak at 1:50 pm CST on Wed., Sept. 30, at the 2026 RBC Capital Markets Global Communications Infrastructure Conference.

For more information, visit investor.csquare.com/events.

About Csquare

Csquare is a leading North American digital infrastructure platform providing carrier-neutral colocation data centers. The company owns and operates a geographically diverse portfolio of data centers across major metropolitan markets in the United States, Canada and the United Kingdom. Csquare delivers secure, reliable infrastructure solutions to enterprise, network, cloud and technology customers, supporting critical workloads, hybrid cloud environments and AI-enabled applications. Headquartered in Dallas, Csquare is committed to operational excellence and long-term customer partnerships. Learn more at www.csquare.com.

SOURCE Csquare, Inc.

Share this article

CHAMBERSBURG, Pa., Sept. 23, 2026 /PRNewswire/ -- Franklin County is wrapping up a busy year of remembering 250 years of American history. No recognition of the county's history would be complete without recalling the events related to John Brown, Frederick Douglass, and the Raid on Harper's Ferry. The public is invited to join Franklin County Visitors Bureau for a Learn & Explore Weekend: Road to Freedom, October 3-4, where the impact of John Brown and Frederick Douglass takes center stage. Nathan Richardson and Doug Dobbs portray Frederick Douglass and John Brown and bring the era's history to life.

The weekend begins with "A Freedom Tour of Franklin County," Saturday, October 3, 9 AM to 3 PM, featuring sites associated with the Underground Railroad, Brown & Douglass, and the USCT. Sunday's program shifts to Frederick Douglass with "Tea & Talk" in the Great Room of the Franklin County 11/30 Visitors Center, 2 PM-4 PM. Inspired by Frederick Douglass' European Tour of 1845-47, the conversation will cover the breadth of his life.

But, this is not just any history event because the Learn & Explore Weekend: Road to Freedom launches the fundraising effort for the John Brown and Frederick Douglass Statue in Chambersburg as well as the Franklin County Road to Freedom Trail, spanning the 1847 Abolition of Slavery Act of Pennsylvania to ratification of the 15th Amendment in 1870. All proceeds will be used to fund the statue; estimated cost is $200,000.

"During the 250th anniversary year, the freedom story highlighted a colonial journey to freedom. As we near the end of 2026, it is important to continue the theme of freedom in this essential year of history with another chapter of freedom," said Janet Pollard, executive director of Franklin County Visitors Bureau. The October 3-4 Learn & Explore Weekend will transport visitors back to the volatile autumn of 1859, a time when Chambersburg--a small town of just over 5000--was the covert staging ground for the raid on Harpers Ferry. October 3 is a Freedom Bus Tour with stops at Mary Ritner Boarding House, capture site of John Cook, home of bounty hunter Daniel Logan, Wertz Farm and USCT cemeteries. October 4 is a Tea & Talk with Frederick Douglass—a reflective conversation covering the seven decades of his life. Preview the event here.

For more details and information on ticketing, visit Eventbrite here. Options are available at a fixed price or by donation to ensure that all with interest are able to participate.

The Franklin County Visitors Bureau invites all to explore history, arts and architecture, recreation, natural beauty, fresh foods, and the warm hospitality of communities like Chambersburg, Greencastle, Mercersburg, Shippensburg, and Waynesboro. For more information, visit ExploreFranklinCountyPA.com or contact the Franklin County Visitors Bureau at 866.646.8060.

SOURCE Franklin County Visitors Bureau

Share this article

SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its intention to offer, subject to market and other conditions, $200.0 million of common stock and $200.0 million aggregate principal amount of convertible senior notes due 2032 (the "notes") in separate public offerings registered under the Securities Act of 1933, as amended. Viking also expects to grant the underwriters of the common stock offering a 30-day option to purchase up to an additional $30.0 million of common stock, and expects to grant the underwriters of the note offering a 30-day option to purchase up to an additional $30.0 million aggregate principal amount of notes solely to cover over-allotments. The completion of the common stock offering will not be contingent on the completion of the note offering, and the completion of the note offering will not be contingent on the completion of the common stock offering.

Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC are acting as joint book-running managers for the note offering and the common stock offering.

The notes will be senior, unsecured obligations of Viking, will accrue interest payable semi-annually in arrears and will mature on October 15, 2032, unless earlier repurchased, redeemed or converted. Noteholders will have the right to convert their notes in certain circumstances and during specified periods. Viking will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Viking's election.

The notes will be redeemable, in whole or in part (subject to certain limitations), for cash at Viking's option at any time, and from time to time, on or after October 22, 2029 and on or before the 25th scheduled trading day immediately before the maturity date, but only if the last reported sale price per share of Viking's common stock exceeds 130% of the conversion price for a specified period of time. The notes will also be redeemable, in whole and not in part, for cash at Viking's election at any time if the principal amount of the notes then outstanding is less than 15% of the aggregate principal amount of the notes issued in this offering (including any additional notes issued pursuant to any exercise of the underwriters' option to purchase additional notes). The redemption price will be equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

If certain corporate events that constitute a "fundamental change" occur, then, subject to a limited exception, noteholders may require Viking to repurchase their notes for cash. The repurchase price will be equal to the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date.

The interest rate, initial conversion rate and other terms of the notes will be determined at the pricing of the note offering.

Viking intends to use the net proceeds from the note offering, together with the net proceeds from the common stock offering, for the continued clinical development, advancement and commercialization of its VK2735 program, the continued clinical development and advancement of its VK3019 program and for other general research and development, working capital and general corporate purposes.

The offerings are being made pursuant to an effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"). Each offering will be made only by means of a prospectus supplement relating to that offering and an accompanying prospectus. An electronic copy of the preliminary prospectus supplement for each offering, together with the accompanying prospectus, is available on the SEC's website at www.sec.gov. Alternatively, copies of each preliminary prospectus supplement, together with the accompanying prospectus, can be obtained by contacting: Morgan Stanley & Co. LLC at 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] and [email protected].

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities referred to in this press release, nor will there be any sale of any such securities, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a clinical-stage biotechnology company advancing a next-generation portfolio of therapies for obesity and metabolic disease. Guided by deep expertise in metabolic biology and rigorous science, Viking is developing innovative treatments to help people achieve meaningful, lasting health improvements by treating obesity first. The company's lead program, VK2735, is a dual glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist in development in both subcutaneous and oral formulations for obesity. VK2735 is currently being evaluated in Phase 3 clinical studies for obesity, along with maintenance dosing strategies designed to support long-term weight management. Viking is also advancing additional obesity programs, including VK3019, an amylin receptor agonist, VK2809, an orally available thyroid hormone receptor beta agonist for metabolic and liver disease, and VK0214 for the rare genetic disorder X-linked adrenoleukodystrophy (X-ALD).

Forward-Looking Statements

This press release contains forward-looking statements regarding Viking Therapeutics, Inc., under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about the anticipated terms of the notes being offered, Vikings ability to complete the offerings on the anticipated terms or at all, the timing and size of the proposed offerings and Viking's intended use of the proceeds. Forward-looking statements represent Viking's current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. Among those risks and uncertainties are market conditions, including market interest rates, the trading price and volatility of Viking's common stock, risks described under the caption "Risk Factors" in the preliminary prospectus supplements for the proposed offerings and risks relating to Viking's business, including those described in Viking's most recent periodic reports filed with the Securities and Exchange Commission, including Viking's Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent Quarterly Reports on Form 10-Q, including the risk factors set forth in those filings. Viking may not consummate the proposed offerings described in this press release and, if the proposed offerings are consummated, cannot provide any assurances regarding the final terms of the offerings or the notes or its ability to effectively apply the net proceeds as described above. The forward-looking statements included in this press release speak only as of the date of this press release, and Viking does not undertake to update the statements included in this press release for subsequent developments, except as may be required by law.

SOURCE Viking Therapeutics, Inc.

Share this article

Gary Brecka announced ULC's expansion into Australia from the stage at the Fortuna One Global Summit in Sydney, with 50 locations planned nationally and Double Bay confirmed as the first, targeted for Q1 2027.

NEWPORT BEACH, Calif., Sept. 23, 2026 /PRNewswire/ -- Ultimate Longevity Center (ULC), the longevity and human-optimization franchise built by Anthony Geisler's Sequel Brands in partnership with human biologist Gary Brecka and precision health platform Lifeforce, is expanding internationally.

Revealed on stage by Brecka at the Fortuna One Global Summit in Sydney, the move brings ULC's global footprint past 300 territories, adding a planned 50-location Australian network to the more than 275 territories the brand has already sold across the U.S. since launching franchise sales in 2026, including 200 in its first four months alone.

"The number one question I get asked every single day is, 'where do I start?'" said Gary Brecka, Co-Founder of Ultimate Longevity Center and Founder of The Ultimate Human. "Australians are just as engaged in this conversation as anyone I meet in the US. They're reading the research, they're asking the questions. ULC is the answer. You walk in, and that's where the journey starts."

Double Bay is confirmed as ULC's first Australian center, targeted to open in Q1 2027, with further flagship locations planned for Melbourne and Brisbane ahead of the brand's 50-center national rollout. ULC Australia will bring the brand's three-zone model – The Lab, The Apothecary and The Playground – to a market Geisler and Brecka see as ready for the same shift underway domestically: longevity moving from a luxury pursuit to an accessible, everyday practice.

"Australia has all the hallmarks of what's driven ULC's franchise growth in the US so far – an engaged, health-conscious population, and no real category leader at the neighbourhood level," said Anthony Geisler, Founder and CEO of Sequel Brands. "We've built one of the fastest-growing franchise sales pipelines in preventive health in under a year, and we see the same opportunity here."

Leading the Australian rollout are Ben Doyle, CEO of ULC Australia & NZ, and Marie Doyle, COO of ULC Australia & NZ. Through their Sydney-based property and investment company Fiducia, the Doyles have spent two decades developing homes and communities across Sydney and will now oversee ULC's Australian network.

"We've spent two decades building places people want to be part of, and ULC gives us the chance to do that for people's health," said Ben Doyle. "We saw immediately what this could mean for Australians, and we're proud to be bringing it here."

Australians interested in becoming an Ultimate Longevity Center member can register their interest at ultimatelongevitycentre.com.au/ffs. Those interested in franchise ownership opportunities can contact [email protected].

ABOUT ULTIMATE LONGEVITY CENTER

Ultimate Longevity Center, a Sequel Brands company co-founded with human biologist Gary Brecka, is a next-generation longevity and performance franchise built around a physician-led, data-driven approach to extending healthspan. Through advanced diagnostics, personalized protocols and integrated recovery technologies, the brand brings the tools of human optimization together under one roof to help people better understand their biology and take a proactive approach to their long-term health. With more than 250 franchise territories sold nationwide since launching franchise sales in 2026, Ultimate Longevity Center is rapidly expanding access to advanced longevity solutions and building a new kind of longevity experience designed for everyday life.

ABOUT GARY BRECKA AND THE ULTIMATE HUMAN

Gary Brecka, the visionary founder of The Ultimate Human, is a renowned Human Biologist, biohacker, and longevity expert. With over two decades of experience in analyzing human biomarkers, Gary's unique approach combines the precision of science with the personal touch of individual wellness.

The Ultimate Human is consistently ranked among the top ten health and wellness podcasts, reaching and impacting millions of lives through its powerful media platform. Through The Ultimate Human, Gary shares his deep knowledge and innovative strategies to help individuals navigate their health journeys. His work is driven by a profound belief in the power of informed, personalized health interventions to transform lives. With Gary's guidance, The Ultimate Human continues to inspire and equip people to become the best versions of themselves, inside and out.

Disclaimer: None of Gary Brecka, Ultimate Human LLC nor any of his or its affiliates, employees, owners or representatives (individually and collectively, "The Ultimate Human") is licensed to provide medical advice nor provides medical advice. Information, advice and recommendations provided by The Ultimate Human is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Individuals should always consult with their physician or another qualified health provider with any questions they may have regarding a medical condition.

ABOUT LIFEFORCE 

Lifeforce is the world's leading longevity-medicine platform, empowering adults to add quality years to their lives through at-home biomarker testing, direct access to expert physicians, precision lifestyle coaching, and science-backed therapies. Thousands of members across the United States have already completed more than one million biomarker tests, with over 80 percent of members reporting quality-of-life and/or health outcomes improvements within their first year. Learn more at mylifeforce.com.

ULC Communications

SOURCE Ultimate Longevity Center

Share this article

Scientific Advisor Nicole Beurkens, PhD, to Promote Brain Health Awareness on QVC as Make Time Wellness Expands Distribution to Meijer Stores

LOS ANGELES, Sept. 23, 2026 /PRNewswire/ -- Make Time Wellness, the rapidly growing women's brain health supplement line founded by Emma Heming Willis, today announced two milestones that further its mission to get the world thinking seriously about women's brain health. Scientific advisor Nicole Beurkens, PhD, will join the QVC family on Friday, September 25, continuing the conversation around the importance of prioritizing brain health with science-backed wellness solutions. Less than a week later, Make Time Wellness will broaden its retail footprint as its products hit Meijer shelves on October 1.

The milestones build on Make Time Wellness's Target debut earlier this year and reflect the brand's growing retail presence and commitment to making conversations, education, and resources around women's brain health easier to access wherever women already shop, learn, and engage.

"Supporting cognitive function, mood, and overall brain resilience is essential at every stage of life. By bringing both education and science-backed solutions to more women through QVC and retailers nationwide, we're helping make brain health a more accessible part of everyday wellness," said Dr. Nicole.

During the QVC Over 50 & Fabulous presentation, viewers will be reintroduced to Make Time Wellness's line of products, specifically the brand's hero product, Make Time for Brain, Body & Beauty. Dr. Nicole will provide viewers with the science behind the products, and answer questions through anecdotes from her clinical experiences.

Make Time Wellness will bring two of its products to Meijer shelves: Make Time for NAD+ & Rhodiola and Brain, Body & Beauty 14-Day Stick Packs. This is the first time the Stick Packs will be available at a national retailer beyond Target, where the product originally launched exclusively earlier this year, further broadening access to Make Time Wellness's growing portfolio.

"We started this movement because women's brain health wasn't part of the everyday wellness conversation," said Emma Heming Willis. "Now we're putting that conversation in front of women on QVC and putting the products on shelves where they shop."

Beyond its product and educational efforts, Make Time Wellness is committed to advancing brain health through its philanthropic initiatives. The brand donates five percent of all proceeds to organizations working to advance brain health research, education, awareness, and caregiver support, including the Emma & Bruce Willis Fund, which supports efforts to combat frontotemporal dementia, and Hilarity for Charity, a non-profit dedicated to assisting families impacted by Alzheimer's and advancing brain health education.

For more information, visit maketimewellness.com.

About Make Time Wellness

Make Time was created to help women prioritize their brain, body, and beauty—in that order, while making more time for themselves. Founder Emma Heming Willis and Founding Partner and Advisor Helen Christoni were surprised by the lack of education, awareness, and products that prioritize women's brain health. They turned their frustration into a global conversation while providing effective wellness products backed by science to help busy women put their brain health and overall wellness above all else. More than a brand, Make Time is a movement, committed to helping women make time for themselves, providing education, and giving back to charity. To learn more about Make Time, visit maketimewellness.com and follow @maketimewellness on Instagram.

Contact:

Make Time Wellness

[email protected] 

SOURCE Make Time Wellness

Share this article

Historic passenger railcars, a locomotive bar and new event experiences are coming to Charlotte's NoDa neighborhood

CHARLOTTE, N.C., Sept. 23, 2026 /PRNewswire/ -- Historic passenger railcars are arriving in Charlotte's NoDa neighborhood, bringing a new destination for celebrations, gatherings and community experiences.

The Aberdeen Carolina & Western Railway (ACWR) will introduce The Magenta Train Charlotte with a ribbon cutting and media meet & greet at 11 a.m. on Thursday, October 22, followed by a public Open House from 4 – 7 p.m.

Guests are invited to step aboard historic railcars, explore the venue and discover what's ahead for The Magenta Train in Charlotte.

FROM RAILROAD HISTORY TO A NEW CHARLOTTE EXPERIENCE

The historic fleet features meticulously restored railcars dating back more than a century and has welcomed guests aboard a variety of acclaimed experiences from its Pinehurst base. From private charters during the U.S. Open and the beloved Carolina Christmas Train to immersive events such as LocoMOTIVE: A Train Murder Mystery and elegant brunch and dinner excursions, The Magenta Train has created memorable journeys for a variety of passengers.

Now, The Magenta Train brings that rich railroad heritage to Charlotte, offering a one-of-a-kind destination where guests can gather, celebrate and connect through an array of private events, public experiences and curated excursions.

While select railcars are expected to return and then remain in Charlotte more permanently in March 2027, portions of the fleet will continue to support event operations and excursions in Pinehurst.

A RIDE FOR EVERY EXPERIENCE

The Magenta Train – Charlotte will offer rental spaces for weddings, receptions, corporate gatherings, private celebrations, rehearsals, community events and entertainment, alongside public programming throughout the year.

The Charlotte property will also be home to Engine Room 87 Locomotive Bar, a distinctive bar experience housed within a locomotive. The self-pour tap bar is designed to offer guests a unique hospitality experience alongside indoor and outdoor gathering spaces, including a rooftop deck, canopy car and bay window lounge.

Although the Engine Room 87 will not be available during the October 22 Open House, it will return with the railcar fleet settling permanently in the Queen City spring 2027.

From milestone celebrations, weddings, and corporate gatherings to community events and nights out, The Magenta Train is creating new ways to experience Charlotte through the character and nostalgia of rail travel.

STEP ABOARD OCTOBER 22

The community is invited to join The Magenta Train Charlotte during its October Open House event.

The Magenta Train – Charlotte Open House

Thursday, October 22, 2026

Ribbon Cutting 11 a.m. // Media and Press Preview 11 a.m. - 1 p.m. // Public Open House 4 – 7 p.m.

409 East 35th Street, Charlotte, NC

Guests can explore select historic passenger railcars, meet the team and learn about upcoming public programming and private event opportunities!

No tickets are required to attend the Open House. To help preserve these historic railcars and ensure a safe experience for all guests, pets are not permitted aboard the train. Please note that the railcars are not wheelchair accessible. All guests will be required to fill out a waiver before touring the train cars onsite.

MEDIA OPPORTUNITIES

Media are invited to experience The Magenta Train ahead of and during the October 22 Open House, with opportunities for behind-the-scenes access, interviews, photography and on-camera coverage.

A ribbon-cutting ceremony will take place at 11 a.m., followed by a media meet & greet and guided walkthroughs until 1 p.m. The media preview will provide an opportunity to explore the space, connect with the team and learn more about The Magenta Train's upcoming Charlotte offerings ahead of the public Open House at 4 p.m.

Media interested in advance access or interview opportunities are encouraged to contact Haley Forgo to coordinate.

ABOUT ABERDEEN CAROLINA & WESTERN RAILWAY

Founded in 1987, the Aberdeen Carolina & Western Railway is a privately held shortline railroad serving central North Carolina. ACWR operates approximately 150 miles of railroad and provides freight, transloading, locomotive and railcar services, as well as passenger and entertainment experiences through its historic railcar collection.

For more information, visit ACWR Entertainment or follow @themagentatraincharlotte on Instagram. Assets are available through the Dropbox links below:

The Magenta Train: Photos, Videos, Articles – approved assets linked here

www.acwr.com/entertainment for event information, tickets, and more

SOURCE Aberdeen Carolina & Western Railway

Share this article

National CORE, Linc Housing and City of Glendale Celebrate Grand Opening of 340 Affordable Apartments for Seniors and Families

GLENDALE, Calif., Sept. 23, 2026 /PRNewswire/ -- Linc Housing and National CORE, nonprofit developers of affordable housing, joined the City of Glendale, public and private partners, community leaders and residents to celebrate the grand opening of Pioneer Village, a 340-home affordable housing community for families and seniors.

"Pioneer Village is a fitting name because it really does take a village to make a project like this happen," said Glendale Mayor Ardy Kassakhian. "The City saw an opportunity with this property years ago and made the decision to invest in affordable housing. Today, that investment has become 340 homes, and that is something worth celebrating. It also shows how Glendale continues to lead on housing efforts and affordability in the region."

Pioneer Village, located at 515 Pioneer Drive in Glendale, includes three elevator-served, five-story buildings on 2.79 acres. The community offers 92 homes reserved for low-income seniors ages 62 and older, 245 homes for families, and three apartments for on-site property staff. Homes are affordable to households earning between 30% and 80% of the area median income.

The buildings are arranged around courtyards and open spaces connected by bridges, with a pedestrian paseo linking the property to nearby Fremont Park. Amenities include more than 5,800 square feet of indoor community space with community rooms, kitchens, computer labs and an on-site gym, along with playgrounds, community gardens, outdoor courtyards with barbecue and picnic areas, rooftop decks and a walking path.

"Pioneer Village brings seniors and families together in an intergenerational community, giving residents the opportunity to deepen their roots in Glendale and build more stable futures," said Suny Lay Chang, president and COO, Linc Housing. "That is the heart of Linc's work: creating homes where people feel secure, connected and part of a community. Pioneer Village was possible through extraordinary partnership among the City of Glendale, the Glendale Housing Authority, CalHFA, Bank of America and National CORE. We are deeply grateful to see that shared commitment become a place people can now call home."

Michael Ruane, president of National CORE, added, "Pioneer Village shows why we need to build at a larger scale. Bringing 340 homes online through one coordinated development allows us to use land, infrastructure and financing more efficiently, so limited resources can help house more people. Opening the doors is only the beginning. Affordable housing works best when it gives people a chance to build community, know their neighbors, connect to services and feel that they belong. This is not just a collection of apartments but a community where families and seniors can deepen their roots."

Pioneer Village began construction in January 2023 and was completed in July 2026. Residents began moving in during June. More than 7,500 unique applications were submitted for the new apartments.

Each home includes air conditioning, electric heating, a patio or balcony, dishwasher, microwave, garbage disposal and all-electric appliances. Pioneer Village is designed to meet LEED Gold standards from the U.S. Green Building Council. The community includes 342 parking spaces in a two-level subterranean garage, including 35 electric-vehicle-ready stalls.

Pioneer Village is within walking distance of Fremont Park and the Glendale Beeline Route 5 stop at Doran and Pacific. It is also within one mile of the Glendale Central Library, Glendale Family Medical Center, grocery stores, restaurants and pharmacies.

Resident services are provided on site by Linc Housing's resident services team. Programs include healthy cooking and eating classes, exercise classes, social activities and supportive services designed to promote health, wellness, connection and access to resources.

Funding for the development comes from a variety of sources, including multifamily housing revenue bond proceeds through Bank of America construction lending, low-income housing tax credits through Bank of America, City of Glendale Measure S Funds, Low and Moderate Income Housing Asset Funds, HOME Program Funds, CalHFA HUD-Risk Sharing Program and Mixed-Income Program Funds, and other private and public funding sources.

"CalHFA is honored to help finance Pioneer Village through our Mixed-Income Program, and I particularly want to celebrate the collaboration that went into this development," said CalHFA Executive Director Tony Sertich. "We saw mission-driven private partners, the City of Glendale and various state government entities all working together with a common goal of providing seniors and families a safe and affordable place to call home."

KFA designed Pioneer Village, and National CORE served as the general contractor. HavenCORE is the property manager, and Linc Housing provides resident services.

About Linc Housing

Linc Housing, one of California's leading nonprofit developers of affordable housing, is committed to building communities and strengthening neighborhoods for underserved populations. Linc has developed more than 10,000 homes in 108 communities statewide. Known for its excellent design, outstanding management and life-enhancing resident services, Linc has more than 40 years of experience serving families, seniors, individuals with special needs and local governments. For more information, visit www.linchousing.org. To donate, visit www.linchousing.org/donate. To stay connected and join the conversation on social media, follow Linc Housing on Instagram @linchousing, LinkedIn Linc Housing, Facebook, and X (formerly Twitter) @LincHousing.

About National CORE and Hope through Housing Foundation

National CORE is one of the largest housing developers in the nation, with a 30-year history of being an innovator in the field. In 2021, National CORE became one of only two affordable housing developers to earn an A+ credit rating from Standard & Poor's Global Ratings. In 2022, National CORE issued $100 million in Series 2022 Social Bonds to accelerate the development of critically needed housing. Serving 30,000 residents, National CORE strives to be a launching pad, not a landing pad, for families struggling financially. In 1998, National CORE created the Hope through Housing Foundation, a philanthropic nonprofit whose mission is to end the cycle of generational poverty through resident services that promote educational attainment, economic mobility and overall well-being.

SOURCE Linc Housing

Share this article